CoChat

Multiple myeloma: evolving genetic events and host interactions

Kuehl, W. Michael, Bergsagel, P. Leif · 2002 · Nature Reviews Cancer

The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.

Abstract

Multiple myeloma is a neoplasm of terminally differentiated B cells (plasma cells) in which chromosome translocations frequently place oncogenes under the control of immunoglobulin enhancers. Unlike most haematopoietic cancers, multiple myeloma often has complex chromosomal abnormalities that are reminiscent of epithelial tumours. What causes full-blown myeloma? And can our molecular understanding of this common haematological malignancy be used to develop effective preventive and treatment strategies?

Overview

Integrity signals

Registry

Crossref · 10.1038/nrc746

Cites

164 of 164 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 6

  1. Jernberg-Wiklund, H. & Nilsson, K. in Human Cell Culture Vol. 3 (eds Masters, J. R. W. & Palsson, B. O.) 81–155 (Kluwer Academic, The Netherlands, 2000).
  2. Avet-Loiseau, H. in VIIIth International Myeloma Workshop 10–11 (Banff, Alberta, Canada, 2001).
  3. Epstein, J., Yaccoby, S. & Fujii, R. in VIIIth International Myeloma Workshop 21–22 (Banff, Alberta, Canada, 2001).
  4. Fonseca, R. et al. A molecular classification of multiple myeloma (MM), based on cytogenetic abnormalities detected by interphase FISH, is powerful in identifying discrete groups of patients with dissimilar prognosis. Blood 98, A733 (2001). · DOI · Paper page
  5. Stinchcombe, T. E. et al. PS-341 is active in multiple myeloma: preliminary reports of a Phase I trial of the proteasome inhibitor PS-341 in patients with hematologic malignancies. Blood 98, A516 (2000).
  6. Bergsagel, P. L. & Kuehl, W. M. in Myeloma: Biology and Management (eds Malpas, J. S., Bergsagel, D. E., Kyle, R. & Anderson, K. C.) (Oxford Univ. Press, Oxford, 1998).

Cited by

See all 818

Metadata

Authors
Kuehl, W. M., & Bergsagel, P. L.
Affiliations
  • National Institutes of Health (US)
  • Cornell University (US)
Venue
Nature Reviews Cancer
Published
2002-03
Volume
2
Issue
3
Pages
175-187
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W1984534203
Cited by
818
References
164
Citations by year
2026: 3 · 2025: 17 · 2024: 16 · 2023: 30 · 2022: 17 · 2021: 15 · 2020: 26 · 2019: 27 · 2018: 24 · 2017: 32 · 2016: 34 · 2015: 37 · 2014: 34 · 2013: 43 · 2012: 38
FWCI
6.71
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature reviews. Cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
Keywords
multiple myeloma, plasma cells, chromosomal translocation, immunoglobulin enhancer, oncogenes, chromosomal abnormalities, host-pathogen interaction, cancer prevention, myeloma treatment, B cell differentiation
MeSH terms
B-Lymphocytes, Enhancer Elements, Genetic, Humans, Immunoglobulins, Multiple Myeloma, Neoplasm Staging, Oncogenes, Translocation, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.